People

(Chief Executive Officer)

(Chief Financial Officer)

(Head of Product Development)

(Chief Operating Officer)

Biomay's Clinical Advisory Board

Biomay is supported by a Clinical Advisory Board (CAB) of world leading allergy specialists. These distinguished and internationally acclaimed scientists agreed to accept the appointment to the CAB:

- Marianne van Hage (Prof. at Karolinska Institute, Stockholm, Sweden)   

- Peter S. Creticos (Prof. at Johns Hopkins University, Baltimore, Maryland, USA)  
  
- Stephen R. Durham (Prof. at Imperial College, London, UK)

- Marek Jutel (Prof. at Wroclaw Medical University, Wroclaw, Poland)

- Hans Ulrich Wahn (Prof. at Charité, Berlin, Germany)

The CAB’s charter is to support the clinical development process of the company’s lead product BM32 through expert advice. The members have committed themselves to support Biomay conducting its clinical development program according to the highest medical standards using cutting edge scientific concepts.